- Home
- MOBX vs OSRH Comparison
MOBX vs OSRH Comparison
Compare MOBX & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | MOBX | OSRH |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.0M | 18.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MOBX | OSRH |
|---|---|---|
| Price | $0.19 | $0.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 26.1M | 937.5K |
| Earning Date | 02-12-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,912,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 53.87 | N/A |
| 52 Week Low | $0.17 | $0.45 |
| 52 Week High | $1.44 | $10.00 |
Technical Indicators
Market Signals| Indicator | MOBX | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 36.37 | 40.98 |
| Support Level | $0.20 | $0.46 |
| Resistance Level | $0.34 | $0.58 |
| Average True Range (ATR) | 0.03 | 0.07 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 5.33 | 16.36 |
Price Performance
Historical ComparisonAbout MOBX Mobix Labs Inc.
Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.